APOE and Alzheimer disease: Therefore, investigation into the association between the APOE genotypes and blood lipids will be instrumental in determining their contribution to AD pathogenesis and their potential as biomarkers of preclinical AD, which are desperately needed to assist with early intervention efforts in AD.